Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, clai...

por Smith, B Douglas, Beach, Charles L, Mahmoud, Dalia, Weber, Laura, Henk, Henry J
Publicado 2014

Correction: Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrosp...

por Smith, B Douglas, Beach, Charles L, Mahmoud, Dalia, Weber, Laura, Henk, Henry J
Publicado 2014

Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis

por Tinajero, Jose, El-Shami, Khaled, Wu, Xiaojun, Smith, B. Douglas, Newman, Matthew J.
Publicado 2022

Acute Leukemia and COVID-19: The Johns Hopkins Experience

por Miller, Karin Paige, Brown, Patrick A., Smith, B. Douglas, Webster, Jonathan, Powell, Helen, Duffield, Amy S.
Publicado 2021

PB1966: THE EFFECT OF BODY MASS INDEX ON THE SAFETY OF BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A POST HOC POOLED DATA ANALYSIS

por Isfort, Susanne, Gambacorti-Passerini, Carlo, Brümmendorf, Tim H, Smith, B. Douglas, Purcell, Simon, Zhao, Huadong, Kuttschreuter, Luke, Apperley, Jane
Publicado 2023

Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo

por Knorr, Katherine L.B., Finn, Laura E., Smith, B. Douglas, Hess, Allan D., Foran, James M., Karp, Judith E., Kaufmann, Scott H.
Publicado 2016

Sorafenib Dose Recommendation in Acute Myeloid Leukemia Based on Exposure‐FLT3 Relationship

por Liu, Tao, Ivaturi, Vijay, Sabato, Philip, Gobburu, Jogarao V. S., Greer, Jacqueline M., Wright, John J., Smith, B. Douglas, Pratz, Keith W., Rudek, Michelle A.
Publicado 2018

Venetoclax exposure‐efficacy and exposure‐safety relationships in patients with treatment‐naïve acute myeloid leukemia who are ineligible for intensive chemotherapy

por Brackman, Deanna, Eckert, Doerthe, Menon, Rajeev, Salem, Ahmed Hamed, Potluri, Jalaja, Smith, B. Douglas, Wei, Andrew H., Hayslip, John, Miles, Dale, Mensing, Sven, Gopalakrishnan, Sathej, Zha, Jiuhong
Publicado 2022

A pharmacodynamic study of sorafenib in patients with relapsed and refractory acute leukemias

por Pratz, Keith W., Cho, Eunpi, Levis, Mark J., Karp, Judith E., Gore, Steven D., McDevitt, Michael, Stine, Adam, Zhao, Ming, Baker, Sharyn D., Carducci, Michael A., Wright, John J., Rudek, Michelle A., Smith, B. Douglas
Publicado 2010

Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy

por Cortes, Jorge E., Heidel, Florian H., Fiedler, Walter, Smith, B. Douglas, Robak, Tadeusz, Montesinos, Pau, Candoni, Anna, Leber, Brian, Sekeres, Mikkael A., Pollyea, Daniel A., Ferdinand, Roxanne, Ma, Weidong Wendy, O’Brien, Thomas, O’Connell, Ashleigh, Chan, Geoffrey, Heuser, Michael
Publicado 2020

Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial

por Heuser, Michael, Smith, B. Douglas, Fiedler, Walter, Sekeres, Mikkael A., Montesinos, Pau, Leber, Brian, Merchant, Akil, Papayannidis, Cristina, Pérez-Simón, José A., Hoang, Caroline J., O’Brien, Thomas, Ma, Weidong Wendy, Zeremski, Mirjana, O’Connell, Ashleigh, Chan, Geoffrey, Cortes, Jorge E.
Publicado 2021

Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized tri...

por Heuser, Michael, Smith, B. Douglas, Fiedler, Walter, Sekeres, Mikkael A., Montesinos, Pau, Leber, Brian, Merchant, Akil, Papayannidis, Cristina, Pérez-Simón, José A., Hoang, Caroline J., O’Brien, Thomas, Ma, Weidong Wendy, Zeremski, Mirjana, O’Connell, Ashleigh, Chan, Geoffrey, Cortes, Jorge E.
Publicado 2021

Impact of Venetoclax and Azacitidine in Treatment-Naïve Patients with Acute Myeloid Leukemia and IDH1/2 Mutations

por Pollyea, Daniel A., DiNardo, Courtney D., Arellano, Martha L., Pigneux, Arnaud, Fiedler, Walter, Konopleva, Marina, Rizzieri, David A., Smith, B. Douglas, Shinagawa, Atsushi, Lemoli, Roberto M., Dail, Monique, Duan, Yinghui, Chyla, Brenda, Potluri, Jalaja, Miller, Catherine L., Kantarjian, Hagop M.
Publicado 2022

Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy

por Goswami, Meghali, Prince, Gabrielle, Biancotto, Angelique, Moir, Susan, Kardava, Lela, Santich, Brian H., Cheung, Foo, Kotliarov, Yuri, Chen, Jinguo, Shi, Rongye, Zhou, Huizhi, Golding, Hana, Manischewitz, Jody, King, Lisa, Kunz, Lauren M., Noonan, Kimberly, Borrello, Ivan M., Smith, B. Douglas, Hourigan, Christopher S.
Publicado 2017

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

por Cortes, Jorge E., Heidel, Florian H., Hellmann, Andrzej, Fiedler, Walter, Smith, B. Douglas, Robak, Tadeusz, Montesinos, Pau, Pollyea, Daniel A., DesJardins, Pierre, Ottmann, Oliver, Ma, Weidong Wendy, Shaik, M. Naveed, Laird, A. Douglas, Zeremski, Mirjana, O’Connell, Ashleigh, Chan, Geoffrey, Heuser, Michael
Publicado 2018

Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study

por Hochhaus, Andreas, Gambacorti-Passerini, Carlo, Abboud, Camille, Gjertsen, Bjørn Tore, Brümmendorf, Tim H., Smith, B. Douglas, Ernst, Thomas, Giraldo-Castellano, Pilar, Olsson-Strömberg, Ulla, Saussele, Susanne, Bardy-Bouxin, Nathalie, Viqueira, Andrea, Leip, Eric, Russell-Smith, T. Alexander, Leone, Jocelyn, Rosti, Gianantonio, Watts, Justin, Giles, Francis J.
Publicado 2020

Increased body mass index is a risk factor for acute promyelocytic leukemia

por Kashanian, Sarah M., Li, Andrew Y., Mustafa Ali, Moaath, Sutherland, Mark E., Duong, Vu H., Hambley, Bryan C., Zacholski, Kyle, El Chaer, Firas, Holtzman, Noa G., Imran, Mohammad, Patzke, Ciera L., Cornu, Jonathan, Duffy, Alison, Dezern, Amy E., Gojo, Ivana, Norsworthy, Kelly J., Levis, Mark J., Smith, B. Douglas, Baer, Maria R., Ghiaur, Gabriel, Emadi, Ashkan
Publicado 2021